Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL

WALTERS GROUP reported a 19.70% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Jan 5, 2026

WALTERS GROUP reported a 19.70% stake in Zentalis Pharmaceuticals, Inc., 13,509,973 shares, as a passive investor on Dec 31, 2025. Filed Jan 5, 2026 (Schedule 13G/A).

Stake
19.70%
Shares
13,509,973
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Walters William T19.70%13,509,973
WALTERS GROUP19.70%13,509,973
Walters, Susan B.19.70%13,509,973

Source

View original at SEC

Related